Search Results for citation:"89 FR 99888"

Found 2 results

Search Results: citation:"89 FR 99888"

💰 Only
Oldest Newest
  • 2024-29076 — Prospective Grant of an Exclusive Patent License: Anti-KK-LC-1 T Cell Receptors for the Treatment of Cancer
    Type:Notice
    Citation:89 FR 99888
    Reading Time:about 3 minutes

    The National Cancer Institute (NCI), part of the National Institutes of Health (NIH) and the Department of Health and Human Services (HHS), is planning to grant an exclusive license to StraightLine Bio, Inc. for certain anti-cancer inventions. These inventions involve patents related to T cell receptors targeting a cancer antigen called KK-LC-1, which is found in certain epithelial cancers. The proposed license would allow StraightLine Bio to develop and commercialize therapies using this technology worldwide, but with some specific exclusions. The public has a chance to comment or object to this plan until December 26, 2024.

    Simple Explanation

    The government wants to let one company use a special recipe to make medicine for some types of cancer, but people can say if they think it's a bad idea until the end of December 2024.

  • 2024-29022 — National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting
    Type:Notice
    Citation:89 FR 99888
    Reading Time:about a minute or two

    The National Institute of Allergy and Infectious Diseases has announced a closed meeting of the Special Emphasis Panel scheduled for January 30, 2025. The meeting is set to take place from 10:30 a.m. to 12:00 p.m. and will be held at the NIH facility in Rockville, MD, with video assistance. The purpose of this meeting is to review and assess grant applications, and it will be closed to the public to prevent the disclosure of confidential trade secrets and personal information. Interested parties can contact Dr. Maryam Rohani for more information.

    Simple Explanation

    The National Institute of Allergy and Infectious Diseases is having a private meeting to talk about which scientists should get money for their projects. They keep this meeting private so secret information isn't shared, but if someone wants to know more, they can ask Dr. Maryam Rohani.